BioNexus Gene Lab Corp [NASDAQ: BGLC] traded at a high on Thursday, posting a 34.00 gain after which it closed the day’ session at $0.85.
The results of the trading session contributed to over 3120980 shares changing hands. Over the past one week, the price volatility of BioNexus Gene Lab Corp stands at 22.36% while the volatility over the past one month is 12.55%.
The market cap for BGLC stock reached $15.10 million, with 17.67 million shares outstanding and 7.07 million shares in the current float. Compared to the average trading volume of 1.49M shares, BGLC reached a trading volume of 3120980 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about BioNexus Gene Lab Corp [BGLC]?
The Average True Range (ATR) for BioNexus Gene Lab Corp is set at 0.10, with the Price to Sales ratio for BGLC stock in the period of the last 12 months amounting to 1.55. The Price to Book ratio for the last quarter was 1.55, with the Price to Cash per share for the same quarter was set at 0.33.
How has BGLC stock performed recently?
BioNexus Gene Lab Corp [BGLC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 26.85. With this latest performance, BGLC shares gained by 17.03% in over the last four-week period, additionally plugging by 36.65% over the last 6 months – not to mention a drop of -92.93% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BGLC stock in for the last two-week period is set at 64.15, with the RSI for the last a single of trading hit 74.39, and the three-weeks RSI is set at 58.69 for BioNexus Gene Lab Corp [BGLC]. The present Moving Average for the last 50 days of trading for this stock 0.7324, while it was recorded at 0.6793 for the last single week of trading, and 1.3272 for the last 200 days.
BioNexus Gene Lab Corp [BGLC]: Deeper insight into the fundamentals
BioNexus Gene Lab Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.24 and a Current Ratio set at 4.93.
Insider trade positions for BioNexus Gene Lab Corp [BGLC]
The top three institutional holders of BGLC stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in BGLC stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in BGLC stock with ownership which is approximately 5.8386%.
